Donald	NP	Donald
Trump	NP	Trump
's	POS	's
victory	NN	victory
in	IN	in
the	DT	the
presidential	JJ	presidential
race	NN	race
,	,	,
often	RB	often
cited	VVN	cite
as	IN	as
a	DT	a
boon	JJ	boon
tofree-market	NN	tofree-market
health	NN	health
care	NN	care
,	,	,
does	VVZ	do
n't	RB	n't
mean	VV	mean
drugmakers	NNS	drugmakers
are	VBP	be
free	JJ	free
of	IN	of
scrutiny	NN	scrutiny
overprices	NNS	overprices
,	,	,
an	DT	an
industry	NN	industry
leader	NN	leader
said	VVD	say
.	SENT	.
U.	NP	U.
S.	NP	S.
pharmaceutical	JJ	pharmaceutical
shares	NNS	share
rose	VVD	rise
after	IN	after
the	DT	the
defeat	NN	defeat
of	IN	of
Democratic	JJ	Democratic
candidate	NN	candidate
HillaryClinton	NP	HillaryClinton
,	,	,
who	WP	who
had	VHD	have
vowed	VVN	vow
to	TO	to
go	VV	go
after	IN	after
companies	NNS	company
'	POS	'
"	``	"
gouging	NN	gouging
.	SENT	.
Yet	RB	yet
if	IN	if
more	JJR	more
pricingscandals	NNS	pricingscandals
emerge	VVP	emerge
like	IN	like
the	DT	the
one	CD	one
that	WDT	that
beset	VVD	beset
Mylan	NP	Mylan
's	POS	's
EpiPen	NN	EpiPen
,	,	,
President-elect	NP	President-elect
Trumpcould	NP	Trumpcould
be	VB	be
more	RBR	more
"	``	"
vicious	JJ	vicious
than	IN	than
Clinton	NP	Clinton
,	,	,
Allergan	NP	Allergan
Chief	NP	Chief
Executive	NP	Executive
Officer	NP	Officer
BrentSaunders	NP	BrentSaunders
said	VVD	say
Thursday	NP	Thursday
.	SENT	.
"	``	"
I	PP	I
worry	VVP	worry
today	NN	today
that	IN/that	that
the	DT	the
pharmaceutical	JJ	pharmaceutical
industry	NN	industry
has	VHZ	have
a	DT	a
very	RB	very
false	JJ	false
sense	NN	sense
of	IN	of
reliefor	NN	reliefor
security	NN	security
because	IN	because
of	IN	of
a	DT	a
Trump	NP	Trump
administration	NN	administration
and	CC	and
Republican-controlledCongress	NN	Republican-controlledCongress
,	,	,
he	PP	he
said	VVD	say
at	IN	at
the	DT	the
Forbes	NP	Forbes
Healthcare	NP	Healthcare
Summit	NP	Summit
in	IN	in
New	NP	New
York	NP	York
.	SENT	.
"	``	"
To	TO	To
think	VV	think
thatPresident-elect	JJ	thatPresident-elect
Trump	NP	Trump
is	VBZ	be
n't	RB	n't
a	DT	a
populist	NN	populist
,	,	,
that	WDT	that
he	PP	he
wo	MD	wo
n't	RB	n't
jump	VV	jump
on	IN	on
the	DT	the
next	JJ	next
EpiPenscandal	NN	EpiPenscandal
and	CC	and
tweet	VV	tweet
more	JJR	more
than	IN	than
Hillary	NP	Hillary
Clinton	NP	Clinton
tweeted	VVD	tweet
or	CC	or
anyone	NN	anyone
else	RB	else
,	,	,
because	IN	because
he'sa	NN	he'sa
prolific	JJ	prolific
tweeter	NN	tweeter
,	,	,
you	PP	you
're	VBP	be
fooling	VVG	fool
yourself	PP	yourself
.	SENT	.
Over	IN	over
the	DT	the
past	JJ	past
18	CD	@card@
months	NNS	month
,	,	,
drug	NN	drug
companies	NNS	company
like	IN	like
Mylan	NP	Mylan
and	CC	and
Valeant	NP	Valeant
PharmaceuticalsInternational	NP	PharmaceuticalsInternational
Inc.	NP	Inc.
,	,	,
along	RB	along
with	IN	with
pharmaceutical	JJ	pharmaceutical
executives	NNS	executive
such	JJ	such
as	IN	as
Martin	NP	Martin
Shkreli	NP	Shkreli
,	,	,
have	VHP	have
become	VVN	become
symbols	NNS	symbol
of	IN	of
rising	VVG	rise
health	NN	health
care	NN	care
costs	NNS	cost
.	SENT	.
Mylan	NP	Mylan
CEO	NP	CEO
Heather	NP	Heather
Bresch	NP	Bresch
,	,	,
whoalso	NP	whoalso
spoke	VVD	speak
at	IN	at
the	DT	the
conference	NN	conference
,	,	,
defended	VVD	defend
the	DT	the
price	NN	price
of	IN	of
EpiPen	NN	EpiPen
,	,	,
saying	VVG	say
that	IN/that	that
thecompany	NN	thecompany
invested	VVN	invest
in	IN	in
the	DT	the
emergency	NN	emergency
allergy	NN	allergy
shot	NN	shot
's	POS	's
design	NN	design
and	CC	and
increasing	VVG	increase
access	NN	access
.	SENT	.
"	``	"
The	DT	the
next	JJ	next
big	JJ	big
scandal	NN	scandal
will	MD	will
revive	VV	revive
the	DT	the
debate	NN	debate
and	CC	and
probably	RB	probably
then	RB	then
some	RB	some
,	,	,
Saunderssaid	NP	Saunderssaid
.	SENT	.
As	IN	as
president	NN	president
,	,	,
Trump	NP	Trump
"	``	"
will	MD	will
be	VB	be
more	RBR	more
vicious	JJ	vicious
,	,	,
more	RBR	more
focused	VVN	focus
,	,	,
on	IN	on
taking	VVG	take
downwhoever	NN	downwhoever
does	VVZ	do
something	NN	something
again	RB	again
.	SENT	.
Trump	NP	Trump
has	VHZ	have
n't	RB	n't
been	VBN	be
shy	JJ	shy
about	IN	about
attacking	VVG	attack
firms	NNS	firm
to	TO	to
force	VV	force
changes	NNS	change
and	CC	and
score	NN	score
politicalpoints	NNS	politicalpoints
.	SENT	.
He	PP	he
's	VBZ	be
claimed	VVN	claim
victory	NN	victory
for	IN	for
pushing	VVG	push
Carrier	NP	Carrier
Corp.	NP	Corp.
to	TO	to
keep	VV	keep
1,000	CD	@card@
jobs	NNS	job
in	IN	in
theU	NN	theU
.	SENT	.
S.	NP	S.
,	,	,
rather	RB	rather
than	IN	than
moving	VVG	move
them	PP	them
to	TO	to
Mexico	NP	Mexico
,	,	,
for	IN	for
instance	NN	instance
.	SENT	.
And	CC	and
attacking	VVG	attack
rising	VVG	rise
drug	NN	drug
prices	NNS	price
had	VHD	have
been	VBN	be
a	DT	a
bipartisan	JJ	bipartisan
venture	NN	venture
.	SENT	.
Hearings	NNS	hearing
thatbrought	VVD	thatbrought
executives	NNS	executive
like	IN	like
Shkreli	NP	Shkreli
and	CC	and
Mylan	NP	Mylan
's	POS	's
Bresch	NP	Bresch
to	TO	to
Washington	NP	Washington
over	IN	over
the	DT	the
costsof	NN	costsof
their	PP$	their
products	NNS	product
were	VBD	be
called	VVN	call
by	IN	by
Republicans	NPS	Republicans
.	SENT	.
During	IN	during
his	PP$	his
campaign	NN	campaign
,	,	,
Trumpcriticized	VVD	Trumpcriticized
the	DT	the
high	JJ	high
cost	NN	cost
of	IN	of
prescription	NN	prescription
drugs	NNS	drug
,	,	,
saying	VVG	say
individuals	NNS	individual
should	MD	should
beallowed	VVN	beallowed
to	TO	to
import	VV	import
cheaper	JJR	cheap
pharmaceuticals	NNS	pharmaceuticals
from	IN	from
abroad	RB	abroad
.	SENT	.
His	PP$	his
transition	NN	transition
website	NN	website
,	,	,
though	RB	though
,	,	,
does	VVZ	do
n't	RB	n't
mention	VV	mention
drug	NN	drug
costs	NNS	cost
.	SENT	.
Vermont	NP	Vermont
Sen.	NP	Sen.
Bernie	NP	Bernie
Sanders	NP	Sanders
has	VHZ	have
been	VBN	be
a	DT	a
foe	NN	foe
of	IN	of
high	JJ	high
drug	NN	drug
prices	NNS	price
as	IN	as
well	RB	well
,	,	,
slammingfirms	NNS	slammingfirms
on	IN	on
Twitter	NP	Twitter
and	CC	and
campaigning	NN	campaigning
in	IN	in
California	NP	California
for	IN	for
an	DT	an
unsuccessful	JJ	unsuccessful
ballotmeasure	NN	ballotmeasure
that	WDT	that
had	VHD	have
promised	VVN	promise
to	TO	to
lower	JJR	low
drug	NN	drug
costs	NNS	cost
in	IN	in
that	DT	that
state	NN	state
.	SENT	.
Clinton	NP	Clinton
,	,	,
meanwhile	RB	meanwhile
,	,	,
last	JJ	last
year	NN	year
sent	VVD	send
the	DT	the
Nasdaq	NP	Nasdaq
Biotechnology	NP	Biotechnology
Index	NP	Index
into	IN	into
free	JJ	free
fall	NN	fall
with	IN	with
a	DT	a
single	JJ	single
tweetdenouncing	NN	tweetdenouncing
"	''	"
price	NN	price
gouging	NN	gouging
.	SENT	.
In	IN	in
August	NP	August
,	,	,
Mylan	NP	Mylan
's	POS	's
shares	NNS	share
plummeted	VVD	plummet
minutes	NNS	minute
after	IN	after
shecalled	VVN	shecalled
for	IN	for
lower	JJR	low
prices	NNS	price
on	IN	on
EpiPen	NN	EpiPen
.	SENT	.
Allergan	NP	Allergan
CEO	NP	CEO
Saunders	NP	Saunders
has	VHZ	have
urged	VVN	urge
the	DT	the
industry	NN	industry
to	TO	to
do	VV	do
more	RBR	more
to	TO	to
help	VV	help
patients	NNS	patient
withthe	JJ	withthe
cost	NN	cost
of	IN	of
drugs	NNS	drug
.	SENT	.
His	PP$	his
company	NN	company
in	IN	in
September	NP	September
said	VVD	say
it	PP	it
would	MD	would
limit	VV	limit
price	NN	price
increasesand	NN	increasesand
would	MD	would
avoid	VV	avoid
"	``	"
price	NN	price
gouging	NN	gouging
actions	NNS	action
or	CC	or
predatory	JJ	predatory
pricing	NN	pricing
.	SENT	.
Allergan	NP	Allergan
shares	NNS	share
have	VHP	have
slumped	VVN	slump
39	CD	@card@
percent	NN	percent
this	DT	this
year	NN	year
,	,	,
while	IN	while
the	DT	the
Standard	NP	Standard
&	CC	&
Poor's500	NP	Poor's500
Index	NP	Index
gained	VVD	gain
7.6	CD	@card@
percent	NN	percent
,	,	,
partly	RB	partly
hurt	VVN	hurt
by	IN	by
industrywide	JJ	industrywide
concerns	NNS	concern
over	IN	over
drugpricing	NN	drugpricing
and	CC	and
pressure	NN	pressure
on	IN	on
makers	NNS	maker
of	IN	of
generics	NNS	generic
.	SENT	.
While	IN	while
saying	VVG	say
it	PP	it
's	VBZ	be
too	RB	too
early	JJ	early
to	TO	to
comment	VV	comment
on	IN	on
Trump	NP	Trump
's	POS	's
choice	NN	choice
of	IN	of
Republican	NP	Republican
Rep.	NP	Rep.
TomPrice	NP	TomPrice
of	IN	of
Georgia	NP	Georgia
for	IN	for
Health	NP	Health
and	CC	and
Human	NP	Human
Services	NPS	Services
Secretary	NP	Secretary
,	,	,
Saunders	NP	Saunders
said	VVD	say
he'soptimistic	JJ	he'soptimistic
given	VVN	give
Price	NP	Price
's	POS	's
experience	NN	experience
as	IN	as
a	DT	a
surgeon	NN	surgeon
.	SENT	.
"	``	"
It	PP	it
's	VBZ	be
a	DT	a
positive	JJ	positive
for	IN	for
health	NN	health
care	NN	care
in	IN	in
general	NN	general
and	CC	and
the	DT	the
pharmaceutical	JJ	pharmaceutical
industry	NN	industry
inparticular	JJ	inparticular
to	TO	to
have	VH	have
someone	NN	someone
who	WP	who
has	VHZ	have
practiced	VVN	practice
medicine	NN	medicine
in	IN	in
the	DT	the
post	NN	post
,	,	,
he	PP	he
said	VVD	say
in	IN	in
aninterview	NN	aninterview
after	IN	after
speaking	VVG	speak
at	IN	at
the	DT	the
conference	NN	conference
.	SENT	.
Saunders	NP	Saunders
said	VVD	say
he	PP	he
is	VBZ	be
n't	RB	n't
interested	JJ	interested
in	IN	in
acquiring	VVG	acquire
either	RB	either
of	IN	of
two	CD	two
Valeant	NP	Valeant
units	NNS	unit
thathave	NNS	thathave
been	VBN	be
involved	VVN	involve
in	IN	in
discussions	NNS	discussion
or	CC	or
speculation	NN	speculation
,	,	,
the	DT	the
Salix	NP	Salix
gastrointestinaldrug	NN	gastrointestinaldrug
business	NN	business
and	CC	and
the	DT	the
Bausch	NP	Bausch
and	CC	and
Lomb	NP	Lomb
eye-care	NN	eye-care
division	NN	division
.	SENT	.
Saunders	NP	Saunders
was	VBD	be
Bausch	NP	Bausch
&Lomb	NP	&Lomb
's	POS	's
chief	JJ	chief
executive	NN	executive
from	IN	from
2010	CD	@card@
to	TO	to
2013	CD	@card@
.	SENT	.
"	``	"
They	PP	they
just	RB	just
do	VVP	do
n't	RB	n't
fit	VV	fit
"	``	"
Allergan	NP	Allergan
's	POS	's
strategy	NN	strategy
,	,	,
he	PP	he
said	VVD	say
.	SENT	.
